| PUBCHEM ID |
90478724
|
| UNII |
L59JN0WVNJ
|
| Preferred Term |
PYRIDOMYCIN DIHYDROCHLORIDE TRIHYDRATE
|
| CAS |
|
| INCHIKEY |
QAVJGOBDOYLMTQ-UFPJFJPLSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC/C(/C)=C(/C(O[C@H](C)[C@@H](C(N[C@@H](Cc1cnccc1)[C@H]([C@H]1C)O)=O)NC(c2ncccc2O)=O)=O)\OC1=O
|
| Total Surface Area |
405,64
|
| Relative PSA |
0,35307
|
| TPSA |
177,04
|
| cLogS |
-2,892
|
| MW |
540,571
|
| cLogP |
1,536
|
| H-Acceptors |
12
|
| H-Donors |
4
|
| Ro5 violations |
2
|
| Druglikeness |
3,4509
|
| DrugScore |
0,506508913005239
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
low
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,1099
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Nucleus
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2423
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5473
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6648
|
| Carcinogenicity (Three-class) |
Non-required
|
